Also downstream of RTK activation is the PI3K/AKT/mTOR pathway regulating diverse cellular functions involved in EAC cancer progression including advanced tumor stage, poor prognosis and therapeutic resistance [49–53]. This evidence concerns the gene AKT1 and cancer.